Imaging pulmonary hypertension in systemic sclerosis
Diagnostic
Systemic sclerosis (SSc) is a disease of blood vessels, skin and other organs. Around 10% of patients with systemic sclerosis develop pulmonary arterial hypertension (PAH), a problem with the blood vessels in the lungs that can ultimately lead to heart failure and death.
Better detection methods are required for PAH to improve early diagnosis and quality of life. This project seeks to improve the identification of PAH in SSc through cutting-edge hyperpolarised imaging.
This will enable better diagnosis and monitoring of PAH for these patients.
The development of a new AI-supported model for imaging the heart based on data from over 700 people with atrial fibrillation, allow ablation to be more personalised to individual patients.
Cardiac patches for heart repair
A trial for every patient
Personalised angina care
Your gifts fund our life saving project